Long-term pre-dialysis extension of darbepoetin treatment versus BAY 85-3934 in Europe and Asia Pacific

Update Il y a 4 ans
Reference: EUCTR2013-001190-24

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

1) To evaluate efficacy of treatment with BAY 85-3934 compared with darbepoetin alfa as measured by change from baseline to post-baseline time points in haemoglobin (Hb) levels. 2) To evaluate safety and tolerability of treatment with BAY 85-3934 compared with darbepoetin by events of special interest, adjudicated serious adverse events (SAEs), and SAEs.


Inclusion criteria

  • Anaemia of Chronic Kidney Disease